NASDAQ: OPHI
Collplant Biotechnologies Ltd Stock Ownership - Who owns Collplant Biotechnologies?

Insider buying vs selling

Have Collplant Biotechnologies Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OPHI insiders and whales buy or sell their stock.

OPHI Shareholders

What type of owners hold Collplant Biotechnologies Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eran Rotem35.75%516,372$1.69MInsider
Hugh M. Evans22.89%330,554$1.08MInsider
Bar Berta Abelis14.29%206,441$677.13kInsider
Yehiel Tal5.54%80,000$262.40kInsider
Ruty Ben Shlomi4.60%66,501$218.12kInsider
Jasmine Seror3.12%45,000$147.60kInsider
Oren Fahimipoor2.08%30,000$98.40kInsider
Philippe Bensimon2.08%30,000$98.40kInsider
Bowman Bagley1.73%25,000$82.00kInsider
Avraham Havron0.69%10,000$32.80kInsider

1 of 2

OPHI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OPHI0.01%93.98%
CDIO0.00%100.00%
PULM0.01%99.99%
AIM0.00%26.25%Net BuyingNet Buying
ALZN0.00%100.00%Net BuyingNet Selling

Collplant Biotechnologies Stock Ownership FAQ

Who owns Collplant Biotechnologies?

Collplant Biotechnologies (NASDAQ: OPHI) is owned by 0.01% institutional shareholders, 93.98% Collplant Biotechnologies insiders, and 6.01% retail investors. Eran Rotem is the largest individual Collplant Biotechnologies shareholder, owning 516,372.00 shares representing 35.75% of the company. Eran Rotem's Collplant Biotechnologies shares are currently valued at $1.86M.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.